Back
ESC Professional Premium Access

Oral fluoroquinolones and risk of aortic dissection and aortic aneurysm: a nationwide nested case-control study

Session: Drug cardiotoxicity: what do we need to know?
Topic: Cardiotoxicity of Drugs
Speaker: Doctor J. Strange (Copenhagen, DK)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jarl Emanuel Strange

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
1 follower

6 more presentations in this session

Berberine associated to SGLT2i Dapagliflozin synergistically reduces cardiac cell apoptosis during exposure to Trastuzumab through reduction of AGEs and IL-6 and induction of pAMPK

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Dose-dependency of diclofenac's cardiovascular risks: a series of nationwide emulated trials

Speaker: Associate Professor M. Schmidt (Aarhus, DK)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular risk following cannabinoid treatment for patients with chronic pain

Speaker: Mrs N. Nouhravesh (Durham, US)

Access
Abstract
Slides
Like
Thumbnail

Pembrolizumab, Ipilimumab and Nivolumab reduces cardiac pAMPK and IL-10, increases vascular NF-kB expression and levels of IL-1b, IL-2 and IL-6 in myocardial tissue

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient

Speaker: Mr E. Fort (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Drug cardiotoxicity: what do we need to know?

Speakers: Doctor J. Strange, Doctor N. Maurea, Associate Professor M. Schmidt, Mrs N. Nouhravesh, Doctor N. Maurea...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources